Does Terbutaline Damage the Developing Heart?

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 68, Issue 6, 2003, Pages 449-455

  Rhodes, Melissa C ^a   Nyska, Abraham ^b   Seidler, Frederic J ^a   Slotkin, Theodore A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

adrenoceptors; Cardiac development; Preterm labor; Terbutaline; Tocolysis

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; TERBUTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PLACENTA BARRIER; CELL COUNT; CELL DAMAGE; CELL DENSITY; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG PENETRATION; DRUG UTILIZATION; FEMALE; HEART DEVELOPMENT; HEART DISEASE; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; MALE; NEWBORN; NONHUMAN; PARAMETER; PERINATAL DRUG EXPOSURE; PREMATURE LABOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TOCOLYSIS;

ADRENERGIC BETA-AGONISTS; ANIMALS; CELL NUCLEUS; FEMALE; HEART; MYOCARDIUM; NECROSIS; PREGNANCY; PREGNANCY, ANIMAL; RATS; RECEPTORS, ADRENERGIC, BETA; TERBUTALINE; TIME FACTORS; TOCOLYSIS; TOCOLYTIC AGENTS;

EID: 0347357896     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.10043     Document Type: Article

References (82)

1. Auman JT, Seidler FJ, Slotkin TA. 2001a. Regulation of fetal cardiac and hepatic β-adrenoceptors and adenylyl cyclase signaling: terbutaline effects. Am J Physiol 281:R1079-R1089.
2. Auman JT, Seidler FJ, Slotkin TA. 2002a. β-Adrenoceptor control of G-protein function in the neonate: determinant of desensitization or sensitization. Am J Physiol 283:R1236-R1244.
3. Auman JT, Seidler FJ, Tate CA, Slotkin TA. 2001b. β -Adrenoceptor-mediated cell signaling in the neonatal heart and liver: responses to terbutaline. Am J Physiol 281:R1895-R1901.
4. Auman JT, Seidler FJ, Tate CA, Slotkin TA. 2002b. Are developing β-adrenoceptors able to desensitize? Acute and chronic effects of β-agonists in neonatal heart and liver. Am J Physiol 283:R205-R217.
5. Bergman B. 1981. Beta-mimetics and the preterm neonatal lung. Acta Physiol Scand Suppl 497:1-52.
6. Bergman B, Bokström H, Borga O, Enk L, Hedner T, Wängberg B. 1984. Transfer of terbutaline across the human placenta in late pregnancy. Eur J Resp Dis 65:81-86.
7. Berkowitz GS, Papiernik E. 1993. Epidemiology of preterm birth. Epidemiol Rev 15:414-443.
8. Bey M, Blanchard AC, Darnell J, Stephens K. 1992. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline for suppression of premature labor. Am J Obstet Gynecol 167:292.
9. Bhat NR, Shanker G, Pieringer RA. 1983. Cell proliferation in growing cultures of dissociated embryonic mouse brain: macromolecule and ornithine decarboxylase synthesis and regulation by hormones and drugs. J Neurosci Res 10:221-230.
10. Briggs MM, Seidler FJ, Slotkin TA, Schachat FH. 1992. Ontogenetic transition of cardiac myosin heavy chain isoforms in rat ventricle: effects of fetal exposure to β-adrenergic agonists or antagonists. J Dev Physiol 17:201-206.
11. Caritis SN, Darby MJ, Chan L. 1988. Pharmacologic treatment of preterm labor. Clin Obstet Gynecol 31:635-651.
12. Claycomb WC. 1976. Biochemical aspects of cardiac muscle differentiation. J Biol Chem 251:6082-6089.
13. Communal C, Singh K, Pimentel DR, Colucci WS. 1998. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 98:1329-1334.
14. Dagbjartsson A, Herbertsson G, Stefansson TS, Kjeld M, Lagercrantz H, Rosen KG. 1989. Beta-adrenoceptor agonists and hypoxia in sheep fetuses. Acta Physiol Scand 137:291-299.
15. Dodic M, Samuel C, Moritz K, Wintour EM, Morgan J, Grigg L, Wong J. 2001. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res 89:623-629.
16. Eisler G, Hjertberg R, Lagercrantz H. 1999. Randomized controlled trial of effect of terbutaline before elective Caesarean section on postnatal respiration and glucose homeostasis. Arch Dis Child 80:F88-F92.
17. Ervin MG, Padbury JF, Polk DH, Ikegami M, Berry LM, Jobe AH. 2000. Antenatal glucocorticoids alter premature newborn lamb neuroendocrine and endocrine responses to hypoxia. Am J Physiol 279:R830-R838.
18. Feenstra MGP. 1992. Functional neuroteratology of drugs acting on adrenergic receptors. Neurotoxicology 13:55-63.
19. Fletcher SE, Fyfe DA, Case CL, Wiles HB, Upshur JK, Newman RB. 1991. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labor. Am J Obstet Gynecol 165:1401-1404.
20. Garofolo MC, Seidler FJ, Auman JT, Slotkin TA. 2002. β-Adrenergic modulation of muscarinic cholinergic receptor expression and function in the developing heart. Am J Physiol 282:R1356-R1363.
21. Garofolo MC, Seidler FJ, Cousins MM, Tate CA, Qiao D, Slotkin TA. 2003. Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver. Brain Res Bull 59:319-329.
22. Gilstrap LC, Christensen R, Clewell WH, D'Alton ME, Davidson EC, Escobedo MB, Gjerdingen DK, Goddard-Finegold J, Goldenberg RL, Grimes DA, Hansen TN, Kauffman RE, Keeler EB, Oh W, Susman EJ, Vogel MG, Avery ME, Ballard RA, Crowley P, Garite T, Hankins GDV, Jobe AH, Koppe JG, Maher JE, Merkatz IR, Shankaran S, Simpson KN, Sinclair JC, Slotkin TA, Taeusch HW, Wright LL. 1994. Effect of corticosteroids for fetal maturation on perinatal outcomes. J Am Med Assoc 273:413-418.
23. Goldenberg RL. 2002. The management of preterm labor. Obstet Gynecol 100:1020-1037.
24. Gu CH, Ma YC, Benjamin J, Littman D, Chao MV, Huang XY. 2000. Apoptotic signaling through the β-adrenergic receptor: a new Gs effector pathway. J Biol Chem 275:20726-20733.
25. Guidotti A. 1972. Adenosine 3′,5′-monophosphate concentrations and isoproterenol-induced synthesis of deoxyribonucleic acid in mouse parotid gland. Mol Pharmacol 8:521-530.
26. Guinn DK, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. 1998. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. Am J Obstet Gynecol 179:874-878.
27. Gupta MP, Gupta M, Jakovcic S, Zak R. 1996. Catecholamines and cardiac growth. Mol Cell Biochem 164:203-210.
28. Hou Q-C, Slotkin TA. 1989. Effects of prenatal dexamethasone or terbutaline exposure on development of neural and intrinsic control of heart rate. Pediatr Res 26:554-557.
29. Hultgårdh-Nilsson A, Querol-Ferrer V, Jonzon B, Krondahl U, Nilsson J. 1994. Cyclic AMP, early response gene expression, and DNA synthesis in rat smooth muscle cells. Exp Cell Res 214:297-302.
30. Joseph X, Bloom S, Pledger G, Balazs T. 1983. Determinants of resistance to the cardiotoxicity of isoproterenol in rats. Toxicol Appl Pharmacol 69:199-205.
31. Kauffman KS, Seidler FJ, Slotkin TA. 1994. Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. Pediatr Res 35:515-522.
32. Kodavanti UP, Moyer C, Ledbetter AD, Schladweiler MC, Costa DL, Hauser R, Christiani DC, Nyska A. 2003. Inhaled environmental combustion particles cause myocardial injury in the Wistar Kyoto rat. Toxicol Sci 71:237-245.
33. Kudlacz EM, Navarro HA, Eylers JP, Dobbins SS, Lappi SE, Slotkin TA. 1989a. Selective linkage of β-adrenergic receptors to functional responses in developing rat lung and liver: phosphatidic acid phosphatase, ornithine decarboxylase and lung liquid reabsorption. J Dev Physiol 12:129-134.
34. Kudlacz EM, Navarro HA, Eylers JP, Lappi SE, Dobbins SS, Slotkin TA. 1989b. Effects of prenatal terbutaline exposure on cellular development in lung and liver of neonatal rat: ornithine decarboxylase activity and macromolecules. Pediatr Res 25:617-622.
35. Kudlacz EM, Navarro HA, Slotkin TA. 1989c. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation. J Pharmacol Exp Ther 250:236-240.
36. Kudlacz EM, Slotkin TA. 1990. Regulation of neonatal rat lung compliance by β-adrenergic receptor stimulation: effects of prenatal exposure to terbutaline or dexamethasone. J Dev Physiol 14:307-310.
37. Lagercrantz H, Slotkin TA. 1986. The "stress" of being born. Sci Am 254:100-107.
38. Lam F, Bergauer NK, Jacques D, Coleman SK, Stanziano GJ. 2001. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations. J Perinatol 21:444-450.
39. Lam F, Elliott J, Jones JS, Katz M, Knuppel RA, Morrison J, Newman R, Phelan J, Willcourt R. 1998. Clinical issues surrounding the use of terbutaline sulfate for preterm labor. Obstet Gynecol Survey 53: S85-S95.
40. Lau C, Kavlock RJ. 1994. Functional toxicity in the developing heart, lung, and kidney. In: Kimmel CA, Buelke-Sam J, Kimmel CA, Buelke-Sam Js, editors. Developmental toxicology, 2nd edition. New York: Raven Press. p 119-188.
41. Lenselink DR, Kuhlmann RS, Lawrence JM, Kolesari GL. 1994. Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo. Am J Obstet Gynecol 171:501-506.
42. Levinsky HV, Procter BG, Malmfors T, Macfarland HN, Rona G. 1978. A three month inhalation toxicity study in the squirrel monkey (Saimiri Sciureus) with terbutaline sulfate (Bricanyl). Toxicology 11:325-328.
43. Long XL, Boluyt MO, Hipolito MD, Lundberg MS, Zheng JS, O'Neill L, Cirielli C, Lakatta EG, Crow MT. 1997. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99:2635-2643.
44. Magnusson G, Hansson E. 1973. Myocardial necrosis in the rat: a comparison between isoprenaline, orciprenaline, salbutamol and terbutaline. Cardiology 58:174-180.
45. Malhotra R, Brosius FC. 1999. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem 274:12567-12575.
46. Marmo E, Vacca C, Cataldi S, Caputi AP. 1974. Cardiac histological and serum-biochemical changes produced by isoprenaline and terbutaline in the pigeon. J Med 5:244-257.
47. McMillian MK, Schanberg SM, Kuhn CM. 1983. Ontogeny of rat hepatic adrenoceptors. J Pharmacol Exp Ther 227:181-186.
48. Morris G, Slotkin TA. 1985. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat. J Pharmacol Exp Ther 233:141-147.
49. Navarro HA, Kudlacz EM, Slotkin TA. 1991. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol Neonate 60:127-136.
50. Palczewski K, Benovic JL. 1991. G-protein-coupled receptor kinases. Trends Biochem Sci 16:387-391.
51. Petersen R, Carter LS, Chescheir NC, Katz VL, Cefalo RC. 1989. Effects of terbutaline sulfate on fetal cardiac function. Am J Obstet Gynecol 161:509-512.
52. Pitzer M, Schmidt MH, Esser G, Laucht M. 2001. Child development after maternal tocolysis with b-sympathomimetic drugs. Child Psychiatry Hum Dev 31:165-182.
53. Portbury AL, Chandra R, Groelle M, McMillian MK, Elias A, Herlong JR, Rios M, Roffler-Tarlov S, Chikaraishi DM. 2003. Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol 284:H2078-H2082.
54. Queisserluft A, Eggers I, Stolz G, Kieningerbaum D, Schlaefer K. 1996. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations. Am J Med Genet 63:268-276.
55. Renick S, Seidler FJ, McCook EC, Slotkin TA. 1997. Neuronal control of cardiac and hepatic macromolecule synthesis in the neonatal rat: effects of sympathectomy. Pediatr Res 41:359-363.
56. Roberts JM, Riemer RK, Bottari SP, Wu YY, Goldfien A. 1989. Hormonal regulation of myometrical adrenergic responses: the receptor and beyond. J Dev Physiol 11:125-134.
57. Robinson BV, Ettedgui JA, Sherman FS. 2001. Use of terbutaline in the treatment of complete heart block in the fetus. Cardiol Young 11:683-686.
58. Sheer D, Morkin E. 1984. Myosin isoenzyme expression in rat ventricle: effects of thyroid hormone analogs, catecholamines, glucocorticoids and high carbohydrate diet. J Pharmacol Exp Ther 229:872-879.
59. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. 1998. β-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol 44:H961-H968.
60. Singh K, Xiao L, Remondino A, Sawyer DB, Colucci WS. 2001. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189:257-265.
61. Skelton R, Gill AB, Parsons JM. 1998. Cardiac effects of short course dexamethasone in preterm infants. Arch Dis Child 78:F133-F137.
62. Slotkin TA, Auman JT, Seidler FJ. 2003. Ontogenesis of β-adrenoceptor signaling: implications for perinatal physiology and for fetal effects of tocolytic drugs. J Pharmacol Exp Ther 306:1-7.
63. Slotkin TA, Lau C, McCook EC, Lappi SE, Seidler FJ. 1994a. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization? Toxicol Appl Pharmacol 127:64-75.
64. Slotkin TA, Lau C, Seidler FJ. 1994b. β-Adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes and coupling to adenylate cyclase via G-proteins. Toxicol Appl Pharmacol 129: 223-234.
65. Slotkin TA, Tate CA, Cousins MM, Seidler FJ. 2001. β-Adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Dev Brain Res 131:113-125.
66. Slotkin TA, Whitmore WL, Orband-Miller L, Queen KL, Haim K. 1987. Beta adrenergic control of macromolecule synthesis in neonatal rat heart, kidney and lung: relationship to sympathetic neuronal development. J Pharmacol Exp Ther 243:101-109.
67. Slotkin TA, Windh R, Whitmore WL, Seidler FJ. 1988. Adrenergic control of DNA synthesis in developing rat brain regions: effects of intracisternal administration of isoproterenol. Brain Res Bull 21:737-740.
68. Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, Seidler FJ. 2000. β-Adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 60:153-166.
69. Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ. 1996. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 271:H2183-H2189.
70. Stein HM, Oyama K, Sapien R, Chappell BA, Padbury JF. 1992. Prolonged β-agonist infusion does not induce desensitization or down-regulation of β-adrenergic receptors in newborn sheep. Pediatr Res 31: 462-467.
71. Stiles GL. 1989. Mechanisms of receptor activation of adenylate cyclase. J Cardiovasc Pharmacol 14:S1-S5.
72. Strang LB. 1991. Fetal lung liquid: secretion and reabsorption. Physiol Rev 71:991-1016.
73. Teerlink JR, Pfeffer JM, Pfeffer MA. 1994. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 75:105-113.
74. Tegner K, Nilsson HT, Persson CGA, Persson K, Ryrfeldt Å. 1984. Elimination pathways of terbutaline. Eur J Resp Dis 65(Suppl): 93-100.
75. Tolson CM, Seidler FJ, McCook EC, Slotkin TA. 1995. Does concurrent or prior nicotine exposure interact with neonatal hypoxia to produce cardiac cell damage? Teratology 52:298-305.
76. 2′-dibutyryl cyclic adenosine 3′,5′-monophosphate in cultured hepatoma cells. Cancer Res 33:1331-1338.
77. Waelbroeck M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, De Smet JM, Robberecht P, Christophe J. J. 1983. The human heart β-adrenergic receptors. II. Coupling of β2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol 24:174-182.
78. Whitehurst VE, Joseph X, Alleva FR, Vick JA, Whittaker P, Zhang J, Fry BE, Balazs T. 1994. Enhancement of acute myocardial lesions by asthma drugs in rats. Toxicol Pathol 22:72-76.
79. Yan LZ, Herrmann V, Hofer JK, Insel PA. 2000. β-Adrenergic receptor/ cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol 279:C1665-C1674.
80. Zecca E, Papacci P, Maggio L, Gallini F, Elia S, De Rosa G, Romagnoli C. 2001. Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial. J Clin Pharmacol 41:1075-1081.
81. Zeiders JL, Seidler FJ, Slotkin TA. 1997. Ontogeny of regulatory mechanisms for β-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J Mol Cell Cardiol 29:603-615.
82. Zhou QY, Quaife CJ, Palmiter RD. 1995. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374:640-643.